Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteosarcoma: basic science and clinical implications.

James B Hayden1, Bang H Hoang

  • 1Department of Orthopedics and Rehabilitation, Oregon Health & Science University, Portland, 97239, USA.

The Orthopedic Clinics of North America
|November 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remotely delivered resistance training program in adult sarcoma survivors: a pilot study.

BMC cancer·2026
Same author

A pan-cancer analysis revealed <i>SKP2</i> as an inhibitor of the tumor immune microenvironment and a promising therapeutic target for immunotherapy.

Precision clinical medicine·2025
Same author

The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental Reprogramming.

bioRxiv : the preprint server for biology·2025
Same author

Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance.

Bioengineering (Basel, Switzerland)·2025
Same author

Survival of Proximal Tibial Endoprostheses Using Compressive Osseointegration: A Multi-Institution Retrospective Study.

Journal of surgical oncology·2025
Same author

Development of Machine Learning Models to Predict Tumor Endoprosthesis Survival.

Journal of surgical oncology·2025
Same journal

New Technologies.

The Orthopedic clinics of North America·2026
Same journal

Recent Innovations and Applications of Custom 3D Printed Cages for Critical Bone Defects in Foot and Ankle Surgery.

The Orthopedic clinics of North America·2026
Same journal

Application of New Technologies: Patient-specific Instrumentation and Artificial Intelligence in the Field of Foot and Ankle.

The Orthopedic clinics of North America·2026
Same journal

Robotic-Assisted Latissimus Dorsi Transfers Around the Shoulder.

The Orthopedic clinics of North America·2026
Same journal

Blood Flow Restriction Therapy for the Upper Extremity: An Emerging Adjunct for Patient Recovery and Rehabilitation.

The Orthopedic clinics of North America·2026
Same journal

The Emerging Roles for 3 Dimensional Printing in Orthopedics: Applications, Evidence, and Future Directions.

The Orthopedic clinics of North America·2026
See all related articles

Identifying patients with poor responses to osteosarcoma treatment is crucial. New biologic markers and therapeutic targets, like growth factors, are being explored to improve outcomes for these individuals.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Current osteosarcoma therapies are effective for 60-70% of patients.
  • Identifying non-responders to standard treatment is a significant clinical challenge.
  • Existing research explores biologic markers and gene expression patterns for treatment stratification.

Purpose of the Study:

  • To investigate novel therapeutic targets for osteosarcoma.
  • To identify potential biomarkers for predicting treatment response.
  • To develop strategies for managing patients with poor prognoses.

Main Methods:

  • Evaluation of growth factors, chemokines, transcription factors, and angiogenic factors.
  • Analysis of microarray data for patient stratification.

Related Experiment Videos

  • Review of current therapeutic approaches and their limitations.

    • Main Results:

    • Several new molecular targets show promise in osteosarcoma.
    • Biomarkers for predicting treatment response are under investigation.
    • Understanding these targets may lead to personalized treatment strategies.

    Conclusions:

    • New therapeutic targets offer potential for treating osteosarcoma patients resistant to standard therapy.
    • Further research into these targets could improve patient outcomes.
    • Personalized medicine approaches are essential for optimizing osteosarcoma treatment.